A modifier of (Na+ + K+) ATPase in commercial ATP-Reference-Cited by-同舟云学术

A modifier of (Na+ + K+) ATPase in commercial ATP

Published:1977-07 Issue:5618 Volume:268 Page:355-356
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

BEAUGÉ L. A.,GLYNN I. M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/268355a0.pdf

Reference6 articles.

1. Beaugé, L. A. & Glynn, I. M. J. Physiol., Lond. 265, 41P–42P (1977).

2. Charney, A. N., Silva, P. & Epstein, F. H. J. appl. Physiol. 39, 156–158 (1975).

3. Katz, A. I. & Michell, A. R. J. Physiol., Lond. 263, 210P–211P (1976).

4. Glynn, I. M. & Ellory, J. C. in Role of Membranes in Secretory Processes (eds Bolis, L., Keynes, R. D. & Wilbrandt, W.) 224–237 (North-Holland, Amsterdam, 1972).

5. Jørgensen, P. L. Biochim. biophys. Acta 401, 399–415 (1975).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ian Michael Glynn. 3 June 1928—7 July 2022;Biographical Memoirs of Fellows of the Royal Society;2023-08-02

2. The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD;Current Issues in Molecular Biology;2023-07-31

3. Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound;International Journal of Molecular Sciences;2021-11-03

4. VANADATE AND PHOSPHOTRANSFERASES WITH SPECIAL EMPHASIS ON OUABAIN/Na,K-ATPASE INTERACTION;Acta Pharmacologica et Toxicologica;2009-03-13

5. Vanadium in diabetes: 100 years from Phase 0 to Phase I;Journal of Inorganic Biochemistry;2006-12